These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1119 related articles for article (PubMed ID: 24346596)
41. Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity. Omeñaca F; Vázquez L; Garcia-Corbeira P; Mesaros N; Hanssens L; Dolhain J; Gómez IP; Liese J; Knuf M Vaccine; 2018 Feb; 36(7):986-996. PubMed ID: 29336924 [TBL] [Abstract][Full Text] [Related]
42. DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers. Lee AW; Jordanov E; Boisnard F; Marshall GS Expert Rev Vaccines; 2017 Feb; 16(2):85-92. PubMed ID: 27996332 [TBL] [Abstract][Full Text] [Related]
43. A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months. Silfverdal SA; Icardi G; Vesikari T; Flores SA; Pagnoni MF; Xu J; Liu GF; Stek JE; Boisnard F; Thomas S; Ziani E; Lee AW Vaccine; 2016 Jul; 34(33):3810-6. PubMed ID: 27288217 [TBL] [Abstract][Full Text] [Related]
44. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel). Johns TL; Hutter GE Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476 [TBL] [Abstract][Full Text] [Related]
45. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States. Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655 [TBL] [Abstract][Full Text] [Related]
46. Disparate kinetics in immune response of two different Martinón-Torres F; Salamanca de la Cueva I; Horn M; Westerholt S; Bosis S; Meyer N; Cheuvart B; Virk N; Jakes RW; Duchenne M; Van den Steen P Hum Vaccin Immunother; 2024 Dec; 20(1):2342630. PubMed ID: 38687024 [TBL] [Abstract][Full Text] [Related]
47. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781 [TBL] [Abstract][Full Text] [Related]
48. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants. Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D; Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207 [TBL] [Abstract][Full Text] [Related]
49. Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants. Li Y; Li RC; Ye Q; Li C; Liu YP; Ma X; Li Y; Zhao H; Chen X; Assudani D; Karkada N; Han HH; Van Der Meeren O; Mesaros N Hum Vaccin Immunother; 2017 Mar; 13(3):588-598. PubMed ID: 27768515 [TBL] [Abstract][Full Text] [Related]
50. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants. Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta AM; Pines E; Blondeau C; Bailleux F; Levine MM Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383 [TBL] [Abstract][Full Text] [Related]
51. Immunogenicity and reactogenicity of DTPa-IPV/Hib vaccine co-administered with hepatitis B vaccine for primary and booster vaccination of Taiwanese infants. Shao PL; Lu CY; Hsieh YC; Bock HL; Huang LM; J Formos Med Assoc; 2011 Jun; 110(6):415-22. PubMed ID: 21741011 [TBL] [Abstract][Full Text] [Related]
52. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine. Tichmann-Schumann I; Soemantri P; Behre U; Disselhoff J; Mahler H; Maechler G; Sänger R; Jacquet JM; Schuerman L Pediatr Infect Dis J; 2005 Jan; 24(1):70-7. PubMed ID: 15665713 [TBL] [Abstract][Full Text] [Related]
53. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines. Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B; Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978 [TBL] [Abstract][Full Text] [Related]
54. Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study. Kim KH; Kim CS; Kim HM; Kim JD; Ma SH; Kim DH; Hwang PH; Han JW; Lee TJ; Kim JH; Karkada N; Mesaros N; Sohn WY; Kim JH Hum Vaccin Immunother; 2019; 15(2):317-326. PubMed ID: 30431387 [TBL] [Abstract][Full Text] [Related]
55. Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants. Vesikari T; Borrow R; Da Costa X; Richard P; Eymin C; Boisnard F; Lockhart S Vaccine; 2017 Jan; 35(3):452-458. PubMed ID: 27939054 [TBL] [Abstract][Full Text] [Related]
56. Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination. Pichichero ME; Blatter MM; Reisinger KS; Harrison CJ; Johnson CE; Steinhoff MC; Senders SD; Rothstein EP; Willems P; Howe BJ Pediatr Infect Dis J; 2002 Sep; 21(9):854-9. PubMed ID: 12352809 [TBL] [Abstract][Full Text] [Related]
57. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067 [TBL] [Abstract][Full Text] [Related]
58. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine. Tejedor JC; Omeñaca F; García-Sicilia J; Verdaguer J; Van Esso D; Esporrín C; Molina V; Muro M; Marés J; Enrubia M; Moraga F; García-Corbeira P; Dobbelaere K; Schuerman L; Pediatr Infect Dis J; 2004 Dec; 23(12):1109-15. PubMed ID: 15626947 [TBL] [Abstract][Full Text] [Related]
59. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine. Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013 [TBL] [Abstract][Full Text] [Related]
60. Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination. Rennels MB; Englund JA; Bernstein DI; Losonsky GA; Anderson EL; Pichichero ME; Munoz FM; Wolff MC Pediatr Infect Dis J; 2000 May; 19(5):417-23. PubMed ID: 10819337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]